Valuation Interpace Biosciences, Inc.

Stocks

Delayed OTC Markets 05:05:06 19/09/26 am AEST			5-day change	1st Jan Change
6.450 ^USD	0.00%		-0.77%	+4.86%

11/08	Interpace Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
13/05	Interpace Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	12.69	31.18	4.437	4.693	11.87	5.448
Change	-	145.72%	-85.77%	5.76%	152.98%	-54.11%
Enterprise Value (EV) ¹	14.8	41.84	15.7	12.39	16.27	4.126
Change	-	182.66%	-62.47%	-21.1%	31.32%	-74.64%
P/E	-0.43x	-2.06x	-0.2x	6.03x	6.84x	1.39x
PBR	-0.44x	-0.74x	-0.07x	-0.08x	-5.36x	0.25x
PEG	-	0x	-0x	-0x	0x	0x
Capitalization / Revenue	0.39x	0.75x	0.14x	0.12x	0.25x	0.14x
EV / Revenue	0.46x	1.01x	0.49x	0.31x	0.35x	0.11x
EV / EBITDA	-0.7x	-6.28x	-12.3x	3.23x	1.93x	0.79x
EV / EBIT	-0.56x	-3.56x	-4.09x	4.41x	2.01x	0.86x
EV / FCF	-2.21x	-25.8x	-15.1x	2.93x	11.5x	0.81x
FCF Yield	-45.2%	-3.87%	-6.64%	34.1%	8.66%	123%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-36.61	-18.09	-25.91	0.8948	1.972	4.426
Distribution rate	-	-	-	-	-	-
Net sales ¹	32.4	41.31	31.84	40.21	46.93	38.73
EBITDA ¹	-21.15	-6.663	-1.28	3.837	8.408	5.209
EBIT ¹	-26.56	-11.74	-3.84	2.811	8.108	4.784
Net income ¹	-26.45	-14.94	-21.96	0.802	6.702	24.58
Net Debt ¹	2.11	10.65	11.26	7.694	4.395	-1.322
Reference price ²	15.700	37.350	5.200	5.400	13.488	6.151
Nbr of stocks (in thousands)	808	835	853	869	880	886
Announcement Date	1/4/21	31/3/22	27/3/23	1/4/24	31/3/25	30/3/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
INTERPACE BIOSCIENCES, INC.	-	-	-	-	35.73M
NATERA, INC.	-268.9x	17.78x	-319.3x	-.--%	52.8B
LABCORP HOLDINGS INC.	23.16x	2.12x	12.01x	0.9%	26.17B
SONIC HEALTHCARE LIMITED	16x	1.26x	7.18x	5.47%	6.89B
RADNET, INC.	1111.14x	-	-	-	6.12B
DR. LAL PATHLABS LIMITED	52.01x	9.6x	33.04x	0.96%	3.36B
GENEDX HOLDINGS CORP.	-31.28x	-	-	-	3.13B
NEOGENOMICS, INC.	-67.14x	-	-	-.--%	2.56B
FLEURY S.A.	15.63x	1.63x	6.36x	5.09%	2.26B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	30.7x	1.59x	11.9x	1.47%	1.85B
Average	97.92x	5.66x	-41.47x	1.99%	10.52B
Weighted average by Cap.	-63.56x	11.16x	-175.16x	0.82%